相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study
Tanya Keenan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
Michael M. Givertz et al.
CIRCULATION (2015)
The effect of angiotensin II receptor blockers on hyperuricemia
Marissa L. Wolff et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2015)
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
Milton Packer et al.
CIRCULATION (2015)
Relation of Serum Uric Acid Levels and Outcomes Among Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan Trial)
Muthiah Vaduganathan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
The role of uric acid in the pathogenesis of human cardiovascular disease
Mehmet Kanbay et al.
HEART (2013)
Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure
Corinna Bergamini et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Impact of oxypurinol in patients with symptomatic heart failure
Joshua M. Hare et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Uric acid and cardiovascular risk
Daniel I. Feig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter
Takashi Iwanaga et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease
J Kanellis et al.
SEMINARS IN NEPHROLOGY (2005)
Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging
SD Anker et al.
CIRCULATION (2003)
A role for uric acid in the progression of renal disease
DH Kang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)